KraneShares Hang Seng TECH Index ETF vs Kenvue Inc. Common Stock — how do they compare? KraneShares Hang Seng TECH Index ETF trades at $11.81 (market cap $45.04M), while Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B). The key difference: Kenvue Inc. Common Stock is far larger — about 756.2× KraneShares Hang Seng TECH Index ETF's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while KraneShares Hang Seng TECH Index ETF pays none. Which is the better fit depends on your goals.
| KTEC | KVUE | |
|---|---|---|
Market Cap | $45.04M | $34.06B |
Volume | 29,043 | 23,267,228 |
Sector | Sector/Thematic | Consumer Staples |
52-Week High | $18.36 | $19.83 |
52-Week Low | $11.41 | $14.11 |
Typical Hold Time | 44 Days | — |
Enterprise Value | — | $41.56B |
Dividend Yield | — | 4.74% |
Signals from Pluang's Aura AI — not financial advice
KTEC trades at $11.81, up 1.99% with bearish technical signals from moving averages. The company reported $120.04M revenue in 2016 with improving net margin (-0.59% vs -4.88% in 2015) and positive operating cash flow of $5.81M. Recent news highlights China's AI competition potentially benefiting tech ETFs like KTEC.
KTEC shows operational improvement but faces profitability challenges with negative net income. The stock's technical weakness and volatile earnings history suggest cautious approach. Upside depends on sustained revenue growth and margin expansion in competitive tech ETF space.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →